SEC Form 4 · Rule 10b5-1 trading plans
Nuvalent, Inc. (NUVL)
- 67Trades filed under a plan
- 6Plan adoption dates stated
- 7Quarterly results prints on file
- 4Trades in the days before a print
In the 2025 filing year, Nuvalent, Inc. filed 23 Form 4 statements whose footnotes name a Rule 10b5-1 trading plan, by 7 reporting owners, covering 67 transactions filed under those plans and 303,666 shares. 23 of those filings carry the SEC's own AFF10B5ONE adoption flag; the other 0 name a plan in a footnote and carry no flag. 7 results prints are on file in the same window, which is what makes the interval below measurable.
Trades filed under a plan in Nuvalent, Inc. 67
- Balcom Alexandra — 2025-01-06 · S · 1,152 shares
- Balcom Alexandra — 2025-01-06 · S · 691 shares
- Balcom Alexandra — 2025-01-06 · S · 2,173 shares
- Miller Deborah Ann — 2025-01-06 · S · 850 shares
- Miller Deborah Ann — 2025-01-06 · S · 510 shares
- Miller Deborah Ann — 2025-01-06 · S · 1,604 shares
- Noci Darlene — 2025-01-06 · S · 1,152 shares
- Noci Darlene — 2025-01-06 · S · 691 shares
- Noci Darlene — 2025-01-06 · S · 2,173 shares
- Pelish Henry E. — 2025-01-06 · S · 712 shares
- Pelish Henry E. — 2025-01-06 · S · 428 shares
- Pelish Henry E. — 2025-01-06 · S · 1,343 shares
Plan adoption dates stated in Nuvalent, Inc. 6
- 2023-12-06 — stated in 7 filings
- 2023-12-21 — stated in 2 filings
- 2024-04-02 — stated in 6 filings
- 2024-11-01 — stated in 2 filings
- 2024-11-18 — stated in 4 filings
- 2024-12-12 — stated in 2 filings
Quarterly results prints on file in Nuvalent, Inc. 7
- 2025-02-27
- 2025-05-08
- 2025-08-07
- 2025-10-30
- 2026-01-14
- 2026-02-26
- 2026-05-07
Trades in the days before a print in Nuvalent, Inc. 4
- 0 days before the 2025-08-07 print — 2025-08-07 · S · Pelish Henry E. · 5,500 shares
- 3 days before the 2025-02-27 print — 2025-02-24 · S · Shair Matthew · 316 shares
- 3 days before the 2025-02-27 print — 2025-02-24 · S · Shair Matthew · 1,382 shares
- 3 days before the 2025-02-27 print — 2025-02-24 · S · Shair Matthew · 302 shares
- 8 days before the 2025-08-07 print — 2025-07-30 · S · Noci Darlene · 4,000 shares
- 9 days before the 2025-02-27 print — 2025-02-18 · S · Porter James Richard · 26,200 shares
- 9 days before the 2025-02-27 print — 2025-02-18 · S · Porter James Richard · 800 shares
- 22 days before the 2025-08-07 print — 2025-07-16 · S · Balcom Alexandra · 14,700 shares
- 23 days before the 2025-08-07 print — 2025-07-15 · S · Balcom Alexandra · 2,484 shares
- 23 days before the 2025-08-07 print — 2025-07-15 · S · Balcom Alexandra · 1,888 shares
- 23 days before the 2025-08-07 print — 2025-07-15 · S · Balcom Alexandra · 874 shares
- 23 days before the 2025-08-07 print — 2025-07-15 · S · Balcom Alexandra · 54 shares
Interval to the next reported results date
For each transaction filed under a plan, the days between the transaction date and the company’s next results print. These are the dates the filings state, printed as an interval; the page draws no conclusion from them.
- 4Within 5 days of a print
- 7Within 10 days of a print
- 0Shortest interval, in days
- 0Trades with no later print on file
- Porter James Richard 2025-02-18 · S · 9 days before the 2025-02-27 print · President and CEO
- Porter James Richard 2025-02-18 · S · 9 days before the 2025-02-27 print · President and CEO
- Shair Matthew 2025-02-24 · S · 3 days before the 2025-02-27 print
- Shair Matthew 2025-02-24 · S · 3 days before the 2025-02-27 print
- Shair Matthew 2025-02-24 · S · 3 days before the 2025-02-27 print
- Noci Darlene 2025-07-30 · S · 8 days before the 2025-08-07 print · Chief Development Officer
- Pelish Henry E. 2025-08-07 · S · 0 days before the 2025-08-07 print · Chief Scientific Officer
Adoption dates, as the filings state them
- 2023-12-06 stated in 7 filings
- 2023-12-21 stated in 2 filings
- 2024-04-02 stated in 6 filings
- 2024-11-01 stated in 2 filings
- 2024-11-18 stated in 4 filings
- 2024-12-12 stated in 2 filings
As the filings state it: “10b5-1 sell-to-cover instruction letter entered into on December 6, 2023”
Reported results dates on file
- 2025-02-27
- 2025-05-08
- 2025-08-07
- 2025-10-30
- 2026-01-14
- 2026-02-26
- 2026-05-07
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 1
- FMC CORP 2
- ELI LILLY & Co 4
- ABEONA THERAPEUTICS INC. 2
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 12
- Lifevantage Corp 1
- IONIS PHARMACEUTICALS INC 29
- VERTEX PHARMACEUTICALS INC / MA 22
- ARROWHEAD PHARMACEUTICALS, INC. 9
Order the document
Every company with plan records →
Form 4 statements and their footnotes from the SEC’s EDGAR full-text search, and this company’s results dates, industry classification and state of incorporation from the SEC submissions API. The page prints the dates the filings state and the interval between them; it draws no conclusion from them.